A parathyroid adenoma will concentrate which of the following radiopharmaceuticals?

A parathyroid adenoma primarily concentrates 99mTc (sestamibi) due to its specific affinity for hyperfunctioning parathyroid tissue. Sestamibi is a radiopharmaceutical that is taken up by cells via mitochondrial metabolism, which is typically elevated in hyperplastic or neoplastic parathyroid glands, such as adenomas. Consequently, this selective uptake allows for the successful imaging of parathyroid adenomas during a sestamibi scan, making it a valuable tool in localizing these tumors prior to surgical intervention.

The other radiopharmaceuticals listed do not have the same specificity for parathyroid tissue. Sodium iodide primarily concentrates in the thyroid, pertechnetate is used for imaging the thyroid and not specifically for parathyroid adenomas, and filtered sulfur colloid is typically used for liver and spleen imaging rather than for parathyroid glands. Therefore, the unique properties of sestamibi make it particularly effective in identifying parathyroid adenomas.